The function of this protein remains unknown.
Applications:
Suitable for use in Western Blot, ELISA
Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:100-500
Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
The function of this protein remains unknown.
Applications:
Suitable for use in Western Blot, ELISA
Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:100-500
Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Shipping & Handling
Shipped In
Cold Packs
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
Specifications
CLASS
Polyclonal Antibodies
*USAGE / SAFETY STATEMENT
For laboratory research and development purposes only.
PURITY
Purified by Protein A affinity chromatography.
APPLICATION
E WB
PHYSICAL FORM
Supplied as a liquid in PBS, pH 7.2, 0.09% sodium azide.
SUBCLASS
Transcription Factors, Zinc (Ring) Finger
HOST SPECIES
human
ISOTYPE
IgG
IMMUNOGEN
RNF145 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 600-627 amino acids from the C-terminal region of human RNF145.
ACCESSION#
NP_653327.1
ANTIBODY TYPE
Pab
GRADE
Affinity Purified
CROSS REACTIVITY
Hu
SPECIFIC ACTIVITY
Human
COMMODITY CODE
30021010
HOST
rabbit
SWISS PROT#
Q96MT1
Questions & Answers (0)
Citations (0)
Shipping & Handling
Shipped In
Cold Packs
Safety & Storage
Storage Temperature
-20°C
Safety Statement
For laboratory research and development purposes only.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.